Central African Gold Inc
Change company Symbol lookup
Select an option...
NDENF Central African Gold Inc
HD Home Depot Inc
ACPS AC Partners Inc
FONR Fonar Corp
WBRRFX BlackRock Russell 2000 Growth Index Fund
WSM Williams-Sonoma Inc
BLK BlackRock Inc
TSEM Tower Semiconductor Ltd
CG Carlyle Group Inc
WDAY Workday Inc
Go

Materials : Metals & Mining | Small Cap Blend
Based in Canada
Company profile

Central African Gold Inc, formerly Bankers Cobalt Corp, is a Canada-based natural resource company. The Company focuses on the acquisition, exploration, development, and operation of mineral projects in the Democratic Republic of the Congo (DRC). The Company’s exploration projects seek copper and cobalt in the DRC. It holds rights to approximately nine mineral projects located in the southern DRC CopperBelt. The Company also focuses to acquire interests in additional concessions.

Closing Price
$0.3136
Day's Change
-0.0014 (-0.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.3136
Day's Low
0.2836
Volume
(Heavy Day)
Volume:
20,250

10-day average volume:
5,430
20,250

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Immunomedics to Gilead Sciences

11:42 am ET September 14, 2020 (Newsfile) Print

New York, New York--(Newsfile Corp. - September 14, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7091/63751_27c83c3644572b8a_001full.jpg



To view an enhanced version of this graphic, please visit:

https://orders.newsfilecorp.com/files/7091/63751_27c83c3644572b8a_001full.jpg

To: All Persons or Entities who purchased Immunomedics, Inc. ("Immunomedics" or the "Company") (NASDAQ: IMMU) stock prior to September 13, 2020.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Immunomedics toGilead Sciences, Inc. ("Gilead") (NASDAQ: GILD). Under the terms of the deal, Gilead will acquire Immunomedics for $88.00 per share in cash.To learn more about the action and your rights, go to:

https://www.zlk.com/mna2/immunomedics-inc-information-request-form

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The Immunomedics merger investigation concerns whether the Board of Immunomedics has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.

Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/63751

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.